Alongside our ongoing commitment to deliver novel therapies in our core focus areas of oncology, immuno-oncology, immunology, and Multiple Sclerosis, EMD Serono is meeting regional commercial needs, striving to offer to patients, and physicians additional products that best complement the company’s global and regional product portfolio.
We continue to extend our commercial portfolio through commercialization and distribution agreements with other pharmaceutical companies:
- We are seeking to grow our portfolio with innovative products across all our core specialty therapeutic areas in mature, and growing markets.
- We are also fueling additional growth via branded portfolio expansion strategies in selected areas of strengths.
Expansion to the portfolio is based on commercial opportunities as well as unmet medical and patient needs.